Government Healthcare Audits and Investigations: Dos and Don'ts Webinar

    This webinar will explore issues affecting the healthcare industry that commonly arise under existing and newly-enacted state and federal regulatory and enforcement schemes. Panelists will focus on how to prepare for, and respond to, government audits and investigations, as well as how to defend against allegations of fraud and misconduct under state and federal statutes. Particular topics include:

    • Responding to and handling inquiries arising in a Medicare or Medicaid audit
    • Examining the anatomy of a formal government investigation and enforcement action under state and federal false claims act and anti-kickback statutes
    • Outlining steps companies should consider taking when responding to an investigation or lawsuit


    John P. McDonald (Partner, Dallas) - John McDonald is co-chair of the Firm's Litigation Department. He has tried cases in both State and Federal Courts throughout the United States. He has over twenty-five years of complex litigation experience on a range of issues with a particular focus on pharmaceutical False Claims Act and Qui Tam litigation including government investigations and trials regarding pharmaceutical pricing, marketing, promotion and FDA regulatory issues as well as fraud and abuse cases related to Stark Law and Anti-Kickback Act violations.  A well-regarded member of the Firm's Litigation Department, he also provides service for clients through Alternative Dispute Resolution, including mediation and arbitration.

    C. Scott Jones (Partner, Dallas) - Scott Jones has tried and defended cases in state and federal court, as well as in arbitration.  His trial and arbitration experience covers a range of issues with a focus on defending pharmaceutical companies in lawsuits and governmental investigations arising under state and federal False Claims Act, Whistleblower, Anti-Kickback, and various Qui Tam statutes.  Mr. Jones frequently advises and represents companies’ current and former officers and employees in connection with governmental investigations, including examinations under oath.  Mr. Jones also enjoys guest lecturing at SMU law school on topics relating to developments in food and drug law, including pharmaceutical marketing and off-label promotion issues.

    Jennifer L. Rangel (Partner, Austin) - Jennifer Rangel focuses on regulatory, transactional and administrative health law. She represents health care providers, health care industry companies and managed care organizations in a variety of matters, including Medicare/Medicaid reimbursement and regulatory issues and fraud and abuse cases related to the Anti-Kickback Act and Stark I/II issues. Ms. Rangel also counsels clients on federal and state certification, HIPAA and data protection, licensing, medical staff credentialing and enforcement, Medicare and Medicaid audits and licensure actions before the Centers for Medicare and Medicaid Services, Texas Health and Human Services Commission, Texas Department of Aging and Disability Services and the Texas Department of State Health Services.

    CLE Credit

    This program is pending approval for 1.0 hour MCLE credit of which 0.5 is ethics credit.
    Please specify the state from which you would like to receive credit when registering.

    Who Should Attend

    Given the nature of the topic, we recommend this CLE to all in-house counsel. 


    Please contact Emily Vodek at evodek@lockelord.com
    or 214-740-8821 for seminar-related questions.


    Explore Additional Topics


    Please understand that your communications with Locke Lord LLP through this website do not constitute or create an attorney-client relationship with Locke Lord LLP. Any information you send to Locke Lord LLP through this website is on a non-confidential and non-privileged basis. Therefore, do not send or include any information in your email that you consider to be confidential or privileged.